MSD Pharmaceuticals LLC
Quick facts
Marketed products
- Antiretroviral/Anti HIV · Infectious Disease / Virology
Antiretroviral drugs inhibit HIV replication by targeting viral enzymes or blocking viral entry into CD4+ T cells.
Phase 3 pipeline
- Golimumab Injection · Immunology
Golimumab is a monoclonal antibody that binds to and inhibits tumor necrosis factor-alpha (TNF-α), reducing inflammatory signaling.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about MSD Pharmaceuticals LLC
What are MSD Pharmaceuticals LLC's marketed drugs?
Top marketed products include Antiretroviral/Anti HIV.
What is MSD Pharmaceuticals LLC's pipeline?
MSD Pharmaceuticals LLC has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Golimumab Injection.
Related
- Antiretroviral/Anti HIV · Infectious Disease / Virology
- Sector hub: All tracked pharma companies